Skip to main content
GDU LC 2023 Main banner
Back

Charles Simone, MD

Memorial Sloan Kettering Cancer Center and New York Proton Center

Charles B. Simone, II, MD, FASTRO, FACRO is Research Professor and Chief Medical Officer of the New York Proton Center and Full Member in Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert in innovative thoracic oncology clinical trial strategies and in proton therapy and SBRT for thoracic malignancies and reirradiation. He was previously Thoracic Oncology Service Chief and Director of Clinical Research and Operations in Radiation Oncology at UPenn. He then became Medical Director of Maryland Proton Treatment Center and Chaired UMaryland’s Comprehensive Cancer Center Clinical Research Committee. He completed undergraduate and medical training at UPenn and radiation oncology residency at NCI/NIH as chief resident.

Dr. Simone is an NIH, NSF, and DOD-funded investigator who has published >510 peer-reviewed scientific articles/chapters, given >475 scientific lectures to national/international audiences, and is national Principal Investigator or Co-Chair of 8 NIH-funded cooperative group trials (NRG Oncology=5, SWOG=1, ECOG-ACRIN=1, PCG=1). He is a three-time Association of Residents in Radiation Oncology Educator of the Year Award winner. He is the Proton Collaborative Group (PCG) Board of Directors President. He Chairs: PCG Lung Committee; NRG Oncology Particle Therapy Work Group; American Society for Radiation Oncology (ASTRO) Lung Resource Panel Committee; ASTRO Blue Ribbon Lung Panel; American Radium Society Appropriate Use Criteria Thoracic Committee; Particle Therapy Co-Operative Group Gastrointestinal Subcommittee; American College of Radiation Oncology Scientific Program Committee; NCI/Radiosurgery Society GRID-Lattice-Microbeam-Flash Radiotherapy Clinical Working Group; FlashForward Consortium Clinical Committee; Varian Proton Connect Users Group. He is Annals of Palliative Medicine Editor-in-Chief.

Presentation(s):